Abstract:Purpose This study seeks to understand the nexus between intellectual capital and profitability of healthcare firms in India with interaction effects. Design/methodology/approach Relevant data were extracted from the Centre for Monitoring Indian Economy (CMIE)'s Prowess database for a period of ten years 2009–2018 for a sample of 84 selected firms from the healthcare industry. This study uses value added intellectual coefficient (VAIC) and modified value added intellectual coefficient (MVAIC) as a measure of intellectual capital. Further, the study employs panel regression techniques to explore the relationship between intellectual capital and profitability. Findings The empirical findings reveal that the intellectual capital coefficient of healthcare firms in India averages 2.7757. It is also observed that a majority of the healthcare firms' intellectual capital coefficient is below the industry average. From the regression analysis, it is evident that the intellectual capital coefficient is positively related to the profitability of healthcare firms in India. As far as the components of intellectual capital coefficient are concerned, the capital employed coefficient (CEC) is the only component driving the profitability of healthcare firms in India. A further introduction of interaction terms improves model explainability and moderates the impact of the predictor variable on the response variable. Furthermore, it is observed that the intellectual capital coefficient of the healthcare industry is immune to changes in political regimes in India. Practical implications The findings reveal that intellectual capital is an important driver of corporate performance, thus healthcare firms in developing economies like India need to enhance their intellectual potential. Therefore, corporates and governments in developing economies should stimulate investments in developing intellectual capital for enhanced corporate performance and economic growth. Thus, this study might be used as a reference by policymakers while drafting the future policy for the development of intellectual capital in general and healthcare sector specifically. Originality/value This is among the first few studies to explore such an empirical relationship for healthcare firms in India and among the few studies of this kind across the globe. It also makes novel contributions in considering interaction variables and seeking the consistency of results across different political regimes. However, the study examines one nation and one industry; thus, the generalisation of findings requires caution.

The contribution of intellectual capital to financial stability in Indian pharmaceutical companies

Impact of Intellectual Capital on the Financial Performance of Innovation-Driven Pharmaceutical Firms: Empirical Evidence from India

Intellectual Capital and Financial Performance: A Comparative Study.

Analyzing the Impact of Intellectual Capital on the Financial Performance: A Comparative Study of Indian Public and Private Sector Banks

Nexus between intellectual capital and profitability with interaction effects: panel data evidence from the Indian healthcare industry

Evaluating Financial Stability and Fraud Detection in Selected Indian Pharmaceutical Companies Using Altman Z Score and Beneish M Score Models

Predictive Analysis of Financial Distress in Pharma Sector: A Quantitative Approach using Altman’s Z-Score Model

The evolution of intellectual capital disclosure driven by European regulatory change: evidence from the Italian stock market

The Relationship Between Intellectual Capital, Financial Stability, Firm Performance, Market Value, and Bankruptcy Risk: Empirical Evidence from Pakistan

Capital Structure Impact on Firm Performance: An Empirical Study of the Pharmaceutical Sector in India

Firm level profitability determinants in Indian drugs and pharmaceutical industry

Enterprise Value and Intellectual Capital: Study of BSE 500 Firms

Risk assessment for pharmaceutical industry in uncertain environment: An integrated multi-criteria decision-making approach

The Impact of Intellectual Capital on Supply Chain Collaboration and Business Performance

Analyzing pharmaceutical industry risks under uncertainty for performance improvement: an Indian scenario

Intellectual capital: the missing link in the corporate social responsibility–financial performance relationship

Exploring the Nonlinear Effect of Intellectual Capital on Financial Performance: Evidence from Listed Shipping Companies in China

An analysis of working capital management in India: An urgent need to refocus

Intellectual capital and financial performance of industrial firms in emerging countries: Empirical evidence from Vietnam

Nonlinearity in the relationship between intellectual capital and corporate performance: evidence from Vietnamese listed companies

INVESTIGATING THE IMPACT OF PROFITABILITY ON THE STOCK PRICES OF SELECTED PHARMACEUTICAL COMPANIES- PRE AND POST IPA 2005 IMPLEMENTATION